OUR PRODUCTS

MOBILE APPS

GENERAL INFO

VTRS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Viatris (VTRS) Earnings Date & Reports

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VTRS is expected to report earnings to 61 cents per share on November 10

Q3'25

Est.

$0.61

Q2'25

Beat

by $0.07

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.07

The last earnings report on August 07 showed earnings per share of 62 cents, beating the estimate of 55 cents. With 3.33M shares outstanding, the current market capitalization sits at 12.46B.

View a ticker or compare two or three

Compare

VTRS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VTRS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VTRS showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

N/A

Address

1000 Mylan Boulevard

Phone

+1 724 514-1800

Employees

38000

Web

https://www.viatris.com